Latest Insider Transactions at Sutro Biopharma, Inc. (STRO)
This section provides a real-time view of insider transactions for Sutro Biopharma, Inc. (STRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SUTRO BIOPHARMA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SUTRO BIOPHARMA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2025
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
3,594
-2.65%
|
$3,594
$1.36 P/Share
|
|
Mar 05
2025
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+6.06%
|
-
|
|
Mar 05
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,594
-3.63%
|
$3,594
$1.36 P/Share
|
|
Mar 05
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+8.12%
|
-
|
|
Mar 05
2025
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,708
-2.24%
|
$6,708
$1.36 P/Share
|
|
Mar 05
2025
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+5.9%
|
-
|
|
Mar 04
2025
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
3,748
-2.87%
|
$3,748
$1.42 P/Share
|
|
Mar 04
2025
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
9,125
+6.53%
|
-
|
|
Mar 04
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,748
-3.99%
|
$3,748
$1.42 P/Share
|
|
Mar 04
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,125
+8.85%
|
-
|
|
Mar 04
2025
|
Jane Chung PRESIDENT AND COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,334
-2.32%
|
$2,334
$1.42 P/Share
|
|
Mar 04
2025
|
Jane Chung PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,875
+7.26%
|
-
|
|
Mar 04
2025
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,136
-3.82%
|
$11,136
$1.42 P/Share
|
|
Mar 04
2025
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,125
+9.64%
|
-
|
|
Mar 01
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,327
-8.93%
|
$8,327
$1.59 P/Share
|
|
Mar 01
2025
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,275
+10.25%
|
-
|
|
Mar 01
2025
|
Jane Chung PRESIDENT AND COO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,450
-9.25%
|
$9,450
$1.59 P/Share
|
|
Mar 01
2025
|
Jane Chung PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,875
+13.91%
|
-
|
|
Mar 01
2025
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
10,320
-7.83%
|
$10,320
$1.59 P/Share
|
|
Mar 01
2025
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
25,125
+9.0%
|
-
|
|
Mar 01
2025
|
Hans Peter Gerber CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,621
-13.06%
|
$4,621
$1.59 P/Share
|
|
Mar 01
2025
|
Hans Peter Gerber CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+24.13%
|
-
|
|
Mar 01
2025
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,203
-8.82%
|
$25,203
$1.59 P/Share
|
|
Mar 01
2025
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,500
+10.81%
|
-
|
|
Mar 01
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,621
-8.01%
|
$4,621
$1.59 P/Share
|
|
Mar 01
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+16.31%
|
-
|
|
Mar 01
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,672
-10.84%
|
$4,672
$1.59 P/Share
|
|
Mar 01
2025
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,375
+12.43%
|
-
|
|
Feb 28
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,405
-24.9%
|
$15,405
$1.59 P/Share
|
|
Feb 28
2025
|
Anne Elizabeth Borgman CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+37.74%
|
-
|
|
Dec 01
2024
|
Jane Chung PRESIDENT AND COO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,920
-11.25%
|
$17,840
$2.69 P/Share
|
|
Dec 01
2024
|
Jane Chung PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+23.98%
|
-
|
|
Sep 18
2024
|
Hans Peter Gerber CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13,380
-35.68%
|
$40,140
$3.95 P/Share
|
|
Sep 18
2024
|
Hans Peter Gerber CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+50.0%
|
-
|
|
Aug 09
2024
|
Jane Chung PRESIDENT AND COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,689
-10.97%
|
$20,067
$3.12 P/Share
|
|
Aug 09
2024
|
Jane Chung PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+23.53%
|
-
|
|
May 01
2024
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-2.73%
|
$2,676
$3.74 P/Share
|
|
May 01
2024
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.12%
|
-
|
|
Apr 11
2024
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,582
-20.11%
|
$30,328
$4.5 P/Share
|
|
Apr 11
2024
|
Venkatesh Srinivasan CHIEF TECH OP OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+36.05%
|
-
|
|
Mar 05
2024
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,108
-4.09%
|
$12,432
$4.54 P/Share
|
|
Mar 05
2024
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+10.32%
|
-
|
|
Mar 05
2024
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,690
-2.95%
|
$26,760
$4.54 P/Share
|
|
Mar 05
2024
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+7.63%
|
-
|
|
Mar 05
2024
|
Edward C Albini CFO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
3,100
-2.82%
|
$12,400
$4.54 P/Share
|
|
Mar 05
2024
|
Edward C Albini CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+7.38%
|
-
|
|
Mar 04
2024
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,739
-5.26%
|
$14,956
$4.79 P/Share
|
|
Mar 04
2024
|
Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,125
+11.38%
|
-
|
|
Mar 04
2024
|
William J Newell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,105
-5.07%
|
$44,420
$4.79 P/Share
|
|
Mar 04
2024
|
William J Newell CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,125
+12.43%
|
-
|